WEIGHT LOSS

New Research Exhibit Scientific Advantages of Affected person- and Supplier-Supportive Expertise in Diabetes Administration

LifeScan research offered on the 15th Worldwide Convention on Superior Applied sciences & Therapies for Diabetes (ATTD) look at how app-based options can assist enhance glycemic management, help with weight reduction, and assist with patient-provider connection in the course of the pandemic

MALVERN, Pa., April 27, 2022 /PRNewswire/ — LifeScan, a world chief in blood glucose monitoring, introduced as we speak the presentation of three research exhibiting the worth of app-based expertise in enhancing diabetes administration. The three research, offered on the 15th Worldwide Convention on Superior Applied sciences & Therapies for Diabetes (ATTD), examined using totally different applied sciences in numerous affected person populations, and all equally concluded {that a} clear profit was noticed for healthcare suppliers and sufferers with diabetes.

Three Diabetes Administration Research offered on the 15th Worldwide Convention on Superior Applied sciences & Therapies for Diabetes (ATTD):

  • “Actual World Proof of Improved Glycemic Management in Folks Utilizing the OneTouch Verio Replicate® Glucose Meter with the OneTouch Reveal® Cellular Software” (EP183)
  • “Engagement and Weight Loss from a Coached Digital Assist Program in Folks with Sort 2 Diabetes” (EP159) 
  • “Scientific Apply Insights Delivering Care Throughout COVID in 5 European Nations Using a Skilled Diabetes Administration Ecosystem” (EP203)

Examine Summaries:

The primary research, a retrospective evaluation of knowledge from greater than 17,000 folks with diabetes, noticed the influence of pairing the OneTouch Reveal affected person app with use of the OneTouch Verio Replicate blood glucose meter. A second research analyzed the good thing about 16 weeks of free entry to Noom’s app-based weight reduction program for folks residing with kind 2 diabetes. The final research, which was revealed within the December 2021 version of the Journal of Diabetes Science and Expertise, thought-about the influence of the pandemic on use of telemedicine throughout 21 European clinics and, particularly, how the OneTouch Reveal digital ecosystem for healthcare suppliers might enhance affected person care. 

“Because the worldwide prevalence of diabetes continues to extend, the challenges dealing with sufferers and their healthcare suppliers was additional exacerbated by the multi-year pandemic impacting our international group, leading to an pressing want for brand spanking new and extra adaptive options,” stated Dr. Elizabeth Holt, Head of International Medical, Scientific, and Security, LifeScan. “Our purpose at LifeScan is to supply folks residing with and treating diabetes the digital instruments and related options that may make its administration simpler and extra profitable. These information offered at ATTD validate our perception that our built-in and interactive digital wellness instruments can meaningfully help folks with diabetes on their path to higher well being.”

Actual World Proof of Improved Glycemic Management in Folks Utilizing the OneTouch Verio Replicate Glucose Meter with the OneTouch Reveal Cellular Software

Utilizing real-world information, this research aimed to grasp if utilizing the OneTouch Reveal cellular app with the OneTouch Verio Replicate meter – synced through Bluetooth® wi-fi expertise – might help sufferers’ modifications in glycemic management. 

To find out this, researchers examined anonymized blood glucose readings with app analytics from a LifeScan server for 4,154 folks with kind 1 diabetes (T1D) and 13,623 folks with kind 2 diabetes (T2D). The analysis appeared on the first 90-day window of mixed use of the OneTouch Reveal app with the OneTouch Verio Replicate meter, particularly evaluating information from the primary 14 days of use to the final 14 days of the 90-day time interval, utilizing paired within-subject variations.

The retrospective evaluation of greater than 17,000 folks with diabetes discovered that utilizing the OneTouch Reveal app with the OneTouch Verio Replicate meter:

  • Improved readings in-range (70-180mg/dL) by +8.1% in T1Ds and +11.2% in T2Ds;
  • Decreased hyperglycemic readings (>180mg/dL) by -8.5% in T1Ds and -11.3% in T2Ds; and
  • Decreased imply glucose by -14.5mg/dL in T1Ds and -18.2mg/dL in T2Ds.

Additional, information confirmed that spending solely 11 to twenty minutes within the OneTouch Reveal app per week improved readings in-range in T1Ds by 8%. Comparable tendencies have been noticed in folks with T2D.

Blood glucose screens (BGM) are important for over 95% of individuals with diabetes who monitor their blood glucose. The OneTouch Reveal cellular app, when related to the OneTouch Verio Replicate BGM, helps sufferers see extra than simply numbers between healthcare supplier visits.  

Engagement and Weight Loss from a Coached Digital Assist Program in Folks with Sort 2 Diabetes

Given the shut correlation between weight problems/obese and kind 2 diabetes (T2D), this research examined the advantages of a digital intervention to help folks residing with T2D trying to lose or higher handle their weight.

To attain this, LifeScan collaborated with Noom®, a number one digital well being platform targeted on conduct change, inviting U.S.-based customers of its OneTouch Reveal diabetes app to enroll in Noom’s app-based weight reduction program for 16 weeks. 400 individuals with a analysis of T2D and A1c of ≥ 7.5% have been enrolled within the research.

Over the 16-week interval, 52,156 in-app actions have been recorded, together with 19,209 way of life articles learn, 15,484 meals recorded, and 6,223 weight measures and 1,481 group postings. 54% of individuals despatched 3,518 teaching messages. The Noom app analyzed information from the 208 (of 400) individuals who recorded weight measurements all through the 16 weeks, and located that:

  • 65% (n=136) of those individuals misplaced weight;
  • “Engaged individuals” (these performing no less than one app motion throughout every of the 16 weeks, n=49) misplaced 9.9lbs, in comparison with 1.9lbs misplaced by those that weren’t engaged; and
  • Members who messaged throughout no less than half of the 16 weeks (n=55) misplaced almost 8lbs greater than those that didn’t (- 9.5lbs in comparison with -1.7lbs).

The research authors concluded that weight reduction amongst sufferers with T2D will be promoted by a coached, digital help program, and that messaging with a coach and/or studying articles on psychology-based understanding of diabetes management could enable for sustained engagement in significant weight reduction. These conclusions are particularly related on condition that the prevalence of weight problems in all US states is over 20% and 89% of US adults with recognized diabetes are obese or overweight. 

Scientific Apply Insights Delivering Care Throughout COVID in 5 European Nations Using a Skilled Diabetes Administration Ecosystem

Revealed within the December 2021 version of the Journal of Diabetes Science and Expertise, this research examined whether or not accelerated adoption of telemedicine might help connectivity between healthcare professionals (HCPs) and the folks they handled for diabetes in the course of the COVID-19 pandemic, when in-person therapy was typically difficult.

To research this, researchers collated survey and in-person information concerning telemedicine from 21 European medical establishments situated in Spain (6), Portugal (1), Germany (5), Belgium (5) and Italy (4). Between November 2020 and January 2021, 22 collaborating HCPs (12 training endocrinologists and 10 diabetes nurses/educators) accomplished surveys and joined digital conferences to report on using telehealth applied sciences inside their clinics earlier than and through COVID.

Moreover, the HCPs shared experiences on using the skilled model of OneTouch Reveal (OTR Professional) digital ecosystem, which permits clinicians to simply entry and overview blood glucose monitoring (BGM) information remotely or in-person with sufferers. The goal was to grasp the influence digital diabetes administration options, like OTR, had in the course of the pandemic.

Examine findings revealed distant consultations elevated 46% throughout the 21 European clinics (Belgium [24%], Spain and Portugal [65%], Germany [34%], Italy [54%]) and distant connection strategies used included phone (60%), electronic mail (19%), video chat (10%), textual content solely (3%), or a mixture of these strategies (8%). HCP survey information additionally discovered that collaborating HCPs reviewed OTR Professional information throughout (45%) or earlier than (25%) consultations, each 3 months (20%) or each 2 weeks (5%). HCPs additionally identified that the OTR Professional app allowed them to remotely examine glucose values and proactively contact sufferers.

Of the 20 HCPs responding to a pre-meeting survey, 55% reported that OTR Professional would turn into their customary of look after diabetes administration going ahead. Additional, 95% agreed OTR Professional recognized patterns and tendencies for extra significant conversations with sufferers.

Concerning the OneTouch® model made by LifeScan

LifeScan is a worldwide chief in blood glucose monitoring and digital well being expertise and has a imaginative and prescient to create a world with out limits for folks with diabetes and associated circumstances. Greater than 20 million folks and their caregivers all over the world depend on LifeScan’s OneTouch model merchandise to handle their diabetes. Collectively, LifeScan and OneTouch enhance the standard of life for folks with diabetes with merchandise and digital platforms outlined by simplicity, accuracy, and belief. LifeScan.com and OneTouch.com.

The Bluetooth® phrase mark and logos are registered logos owned by Bluetooth SIG, Inc. and any use of such marks by LifeScan Scotland Ltd. and its associates is beneath license.

SOURCE Lifescan, Inc.

Related Articles

Back to top button